Dermatitis, Eczematous Recruiting Phase 4 Trials for Dupilumab (DB12159)

Also known as: Eczema / Eczematous dermatitis / Eczema NOS / Eczematous rash / Dermatitis eczematoid

IndicationStatusPhase
DBCOND0057011 (Dermatitis, Eczematous)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03293030Immunogenetic Profiling of Dupilumab for the Treatment of Atopic DermatitisTreatment